Home/Filings/4/0000882104-20-000197
4//SEC Filing

Stone Christopher Lewis 4

Accession 0000882104-20-000197

CIK 0000882104other

Filed

Dec 3, 7:00 PM ET

Accepted

Dec 4, 9:17 PM ET

Size

4.8 KB

Accession

0000882104-20-000197

Insider Transaction Report

Form 4
Period: 2020-12-02
Stone Christopher Lewis
VP and General Counsel
Transactions
  • Disposition to Issuer

    Common stock

    2020-12-0211,544605,559 total
Footnotes (1)
  • [F1]Disposition of a portion of a restricted stock award due to performance criteria not being achieved under equity incentive plans.

Issuer

PDL BIOPHARMA, INC.

CIK 0000882104

Entity typeother

Related Parties

1
  • filerCIK 0001453373

Filing Metadata

Form type
4
Filed
Dec 3, 7:00 PM ET
Accepted
Dec 4, 9:17 PM ET
Size
4.8 KB